Patients at Henry Ford Hospital now have a new cancer treatment available that offers an alternative cancer surgery, without the incision or hospital stay, treating patients in 15 minutes or less and returning them to their everyday lives.
The Edge™ Radiosurgery Suite is designed to perform advanced, non-invasive cancer procedures anywhere in the body – including the brain, spine, head and neck, adrenal gland, lung, liver and pancreas – with extreme precision and low toxicity.
It is the first unit in North America and only available at the Josephine Ford Cancer Institute at Henry Ford Hospital.
The Edge, created by Varian Medical Systems, uses new real-time tumor tracking technology and motion management capabilities, improving both safety and comfort for patients by protecting healthy tissue with sub-millimeter-accuracy. And its “cutting edge” beam offers the agility to treat tumors that may be difficult to reach surgically.
Treatments are typically outpatient and completed within the same week – with only one to five sessions.
Patients will begin treatment using the Edge this week at Henry Ford Hospital.
A pioneer in the use stereotactic radiation therapy, Henry Ford’s Department of Radiation Oncology has treated more than 4,000 patients using this specialized type of stereotactic radiation therapy.
And now, the Edge offers patients:
• Faster treatment: With a dose rate of up to 2,400 monitor units per minute, it offers rapid stereotactic treatments in only 10-20 minutes compared to other systems that can take well over an hour per session.
• Increased comfort: The six degrees (6D) of freedom treatment couch provides the accuracy, precision and flexibility needed to optimally position and adjust patients, allowing them to be comfortable and breathe freely during treatment.
• Real-time imaging: An advanced motion management package makes it possible to better compensate for tumor motion during treatment. The 2.5mm multi-leaf collimator provides a distinct cutting “edge” for radiosurgery treatments.
• Cost-effective medicine: The Edge can accurately treat the vast majority of what a proton beam center can do at a fraction of the cost of a proton unit.
“Henry Ford’s Department of Radiation Oncology has a long tradition of expertise with the most advanced radiation technologies, a heritage that will now continue with the addition the Edge,” says Benjamin Movsas, M.D., Chair of the Department of Radiation Oncology at Henry Ford.
“The Edge truly represents a novel platform in radiosurgery, offering a system that provides a fully-integrated solution for planning and administering radiosurgery treatments.”
“In radiosurgery, millimeters matter,” says neurosurgeon Steven N. Kalkanis, M.D., director of the Center for Cancer Surgery at Henry Ford. “The Edge radiosurgery suite is calibrated for sub-millimeter accuracy. That will help us rest assured that we are doing everything possible to protect normal tissues.”
Henry Ford Hospital was selected by Varian as the first site for the Edge in North American because it “represents and embodies clinical excellence and we are thrilled that we get to launch this exciting new platform into clinical use with them,” according to Chris Toth, vice president of marketing for Varian’s Oncology Systems business.
Henry Ford joins Champalimaud Foundation in Lisbon, Portugal, as the first two sites in the world with the Edge.
What is Stereotactic Radiation?
Stereotactic radiation is a procedure that precisely delivers intense radiation doses to tumor targets in one to five treatments. The goal of this non-invasive procedure is to destroy, or make inactive, the tumor while minimizing dose exposure to the surrounding healthy tissue.
The Latest on: Stereotactic Radiation
via Google News
The Latest on: Stereotactic Radiation
- Fujitsu And University Of Toronto Researchers Develop Quantum-Inspired Technology To Optimize Radiation Treatment Planson February 26, 2021 at 10:18 am
Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto (U of T) today announced the development of a technology for dramatically streamlining the creation of ...
- Fujitsu and University of Toronto develop technology to optimize radiation treatment planson February 26, 2021 at 8:05 am
Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto today announced the development of a technology for dramatically streamlining the creation of radiation ...
- Nurse ‘proud to be first in world’ to insert prostate implanton February 25, 2021 at 8:38 am
A nurse in Middlesbrough is believed to have become the first in the world to be trained to insert a revolutionary implant, which helps to reduce the side ...
- The Radiosurgery Society Announces Launch of Joint Accreditation Program with The American College of Radiation Oncologyon February 25, 2021 at 6:29 am
The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, today announced the launch of a joint accreditation with the ...
- Specialized doctor brings new technology to the Valley for fighting against canceron February 24, 2021 at 3:46 pm
Mercy Health has brought in a new radiation oncologist from UPMC in Pittsburgh who has expertise in cancer treatment. Dr. Dwight Heron said he’s really excited to bring new technology, new treatment ...
- Teesside nurse becomes first in the world to be trained for revolutionary implant in cancer patientson February 23, 2021 at 3:00 am
A Teesside nurse has become the first in the world to be trained to insert a revolutionary implant. Helen Scullion is leading the way as the first advanced nurse practitioner to insert SpaceOAR ...
- Stereotactic Surgery Devices Market Size Worth Around US$ 30.9 Billion by 2030on February 23, 2021 at 1:05 am
The global Stereotactic Surgery Devices market size is expected to be worth around US$ 30.9 billion by 2030, according to a new report by Vision Research Reports. The global Stereotactic Surgery ...
- Global Radiation Therapy Market Delivers Top Companies Analysis, Regions and Applications 2024on February 19, 2021 at 2:54 pm
The global radiation therapy market is expected to reach US$10.11 billion in 2024, witnessing growth at a CAGR of ...
- Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic canceron February 18, 2021 at 1:32 pm
To perform a comparison of the different stereotactic body radiotherapy (SBRT) plans between the Varian EDGE and CyberKnife (CK) systems for locally advanced unresectable pancreatic cancer. Fifteen ...
- 2021 Prostate Cancer - Zachary Klaassen + Christopher Wallis (Stereotactic Ablative Body Radiotherapy in Patients with Oligometastatic Cancers) - 2004on February 17, 2021 at 10:37 pm
Hello, and thank you for joining us for this UroToday Journal Club. I'm Chris Wallis, a Fellow in Urological Oncology at Vanderbilt. And with me today is Zach Klaassen, an Assistant Professor in the ...
via Bing News